|
1
|
Donahoe SM, Stewart GC, McCabe CH,
Mohanavelu S, Murphy SA, Cannon CP and Antman EM: Diabetes and
mortality following acute coronary syndromes. JAMA. 298:765–775.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xu J, Li H, Irwin MG, Xia ZY, Mao X, Lei
S, Wong GT, Hung V, Cheung CW, Fang X, et al: Propofol ameliorates
hyperglycemia-induced cardiac hypertrophy and dysfunction via heme
oxygenase-1/signal transducer and activator of transcription 3
signaling pathway in rats. Crit Care Med. 42:e583–e594. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu X, Wei J, Peng DH, Layne MD and Yet
SF: Absence of heme oxygenase-1 exacerbates myocardial
ischemia/reperfusion injury in diabetic mice. Diabetes. 54:778–784.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Koka S, Das A, Salloum FN and Kukreja RC:
Phosphodiesterase-5 inhibitor tadalafil attenuates oxidative stress
and protects against myocardial ischemia/reperfusion injury in type
2 diabetic mice. Free Radic Biol Med. 60:80–88. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zheng Z, Chen H, Li J, Li T, Zheng B,
Zheng Y, Jin H, He Y, Gu Q and Xu X: Sirtuin 1-mediated cellular
metabolic memory of high glucose via the LKB1/AMPK/ROS pathway and
therapeutic effects of metformin. Diabetes. 61:217–228. 2012.
View Article : Google Scholar
|
|
6
|
Nadtochiy SM, Yao H, McBurney MW, Gu W,
Guarente L, Rahman I and Brookes PS: SIRT1-mediated acute
cardioprotection. Am J Physiol Heart Circ Physiol. 301:H1506–H1512.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pillai VB, Sundaresan NR and Gupta MP:
Regulation of Akt signaling by sirtuins: Its implication in cardiac
hypertrophy and aging. Circ Res. 114:368–378. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hori YS, Kuno A, Hosoda R and Horio Y:
Regulation of FOXOs and p53 by SIRT1 modulators under oxidative
stress. PLoS One. 8:e738752013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang Y, Duan W, Li Y, Jin Z, Yan J, Yu S
and Yi D: Novel role of silent information regulator 1 in
myocardial ischemia. Circulation. 128:2232–2240. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Menegazzi M, Tedeschi E, Dussin D, De
Prati AC, Cavalieri E, Mariotto S and Suzuki H: Anti-interferon
gamma action of epigallocatechin-3-gallate mediated by specific
inhibition of STAT1 activation. FASEB J. 15:1309–1311.
2001.PubMed/NCBI
|
|
11
|
Townsend PA, Scarabelli TM, Pasini E,
Gitti G, Menegazzi M, Suzuki H, Knight RA, Latchman DS and
Stephanou A: Epigallocatechin-3-gallate inhibits STAT-1 activation
and protects cardiac myocytes from ischemia/reperfusion-induced
apoptosis. FASEB J. 18:1621–1623. 2004.PubMed/NCBI
|
|
12
|
Hsieh SR, Hsu CS, Lu CH, Chen WC, Chiu CH
and Liou YM: Epigallocatechin-3-gallate-mediated cardioprotection
by Akt/GSK-3β/caveolin signalling in H9c2 rat cardiomyoblasts. J
Biomed Sci. 20:862013. View Article : Google Scholar
|
|
13
|
Sulaiman M, Matta MJ, Sunderesan NR, Gupta
MP, Periasamy M and Gupta M: Resveratrol, an activator of SIRT1,
upregulates sarcoplasmic calcium ATPase and improves cardiac
function in diabetic cardiomyopathy. Am J Physiol Heart Circ
Physiol. 298:H833–H843. 2010. View Article : Google Scholar :
|
|
14
|
Queen BL and Tollefsbol TO: Polyphenols
and aging. Curr Aging Sci. 3:34–42. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li H, Yao W, Irwin MG, Wang T, Wang S,
Zhang L and Xia Z: Adiponectin ameliorates hyperglycemia-induced
cardiac hypertrophy and dysfunction by concomitantly activating
Nrf2 and Brg1. Free Radic Biol Med. 84:311–321. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lambert JD, Lee MJ, Diamond L, Ju J, Hong
J, Bose M, Newmark HL and Yang CS: Dose-dependent levels of
epigal-locatechin-3-gallate in human colon cancer cells and mouse
plasma and tissues. Drug Metab Dispos. 34:8–11. 2006. View Article : Google Scholar
|
|
17
|
Hsieh SR, Tsai DC, Chen JY, Tsai SW and
Liou YM: Green tea extract protects rats against myocardial
infarction associated with left anterior descending coronary artery
ligation. Pflugers Arch. 458:631–642. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu L, Sun Y, Cheng L, Jin Z, Yang Y, Zhai
M, Pei H, Wang X, Zhang H, Meng Q, et al: Melatonin
receptor-mediated protection against myocardial
ischemia/reperfusion injury: Role of SIRT1. J Pineal Res.
57:228–238. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yan J, Feng Z and Liu J, Shen W, Wang Y,
Wertz K, Weber P, Long J and Liu J: Enhanced autophagy plays a
cardinal role in mitochondrial dysfunction in type 2 diabetic
Goto-Kakizaki (GK) rats: Ameliorating effects of
(−)-epigallocatechin-3-gallate. J Nutr Biochem. 23:716–724. 2012.
View Article : Google Scholar
|
|
20
|
Wu Y, Xia ZY, Dou J, Zhang L, Xu JJ, Zhao
B, Lei S and Liu HM: Protective effect of ginsenoside Rb1 against
myocardial ischemia/reperfusion injury in streptozotocin-induced
diabetic rats. Mol Biol Rep. 38:4327–4335. 2011. View Article : Google Scholar
|
|
21
|
Yamazaki KG, Romero-Perez D,
Barraza-Hidalgo M, Cruz M, Rivas M, Cortez-Gomez B, Ceballos G and
Villarreal F: Short- and long-term effects of (−)-epicatechin on
myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ
Physiol. 295:H761–H767. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yanagi S, Matsumura K, Marui A, Morishima
M, Hyon SH, Ikeda T and Sakata R: Oral pretreatment with a green
tea poly-phenol for cardioprotection against ischemia-reperfusion
injury in an isolated rat heart model. J Thorac Cardiovasc Surg.
141:511–517. 2011. View Article : Google Scholar
|
|
23
|
Kim CJ, Kim JM, Lee SR, Jang YH, Kim JH
and Chun KJ: Polyphenol (−)-epigallocatechin gallate targeting
myocardial reperfusion limits infarct size and improves cardiac
function. Korean J Anesthesiol. 58:169–175. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Piao CS, Kim DS, Ha KC, Kim HR, Chae HJ
and Chae SW: The protective effect of epigallocatechin-3 gallate on
ischemia/reperfusion injury in isolated rat hearts: An ex vivo
approach. Korean. J Physiol Pharmacol. 15:259–266. 2011. View Article : Google Scholar
|
|
25
|
Kim SJ, Li M, Jeong CW, Bae HB, Kwak SH,
Lee SH, Lee HJ, Heo BH, Yook KB and Yoo KY:
Epigallocatechin-3-gallate, a green tea catechin, protects the
heart against regional ischemia-reperfusion injuries through
activation of RISK survival pathways in rats. Arch Pharm Res.
37:1079–1085. 2014. View Article : Google Scholar
|
|
26
|
Lejay A, Fang F, John R, Van JA, Barr M,
Thaveau F, Chakfe N, Geny B and Scholey JW: Ischemia reperfusion
injury, ischemic conditioning and diabetes mellitus. J Mol Cell
Cardiol. 91:11–22. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Arts IC, Hollman PC, Feskens EJ, Bueno de
Mesquita HB and Kromhout D: Catechin intake and associated dietary
and lifestyle factors in a representative sample of Dutch men and
women. Eur J Clin Nutr. 55:76–81. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu TT, Liang NS, Li Y, Yang F, Lu Y, Meng
ZQ and Zhang LS: Effects of long-term tea polyphenols consumption
on hepatic microsomal drug-metabolizing enzymes and liver function
in Wistar rats. World J Gastroenterol. 9:2742–2744. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shi Z, Fu F, Yu L, Xing W, Su F, Liang X,
Tie R, Ji L, Zhu M, Yu J, et al: Vasonatrin peptide attenuates
myocardial ischemia-reperfusion injury in diabetic rats and
underlying mechanisms. Am J Physiol Heart Circ Physiol.
308:H281–H290. 2015. View Article : Google Scholar
|
|
30
|
Niu Y, Na L, Feng R, Gong L, Zhao Y, Li Q,
Li Y and Sun C: The phytochemical, EGCG, extends lifespan by
reducing liver and kidney function damage and improving
age-associated inflammation and oxidative stress in healthy rats.
Aging Cell. 12:1041–1049. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lambert JD, Kennett MJ, Sang S, Reuhl KR,
Ju J and Yang CS: Hepatotoxicity of high oral dose
(−)-epigallocatechin-3-gallate in mice. Food Chem Toxicol.
48:409–416. 2010. View Article : Google Scholar
|
|
32
|
Xue R, Lei S, Xia ZY, Wu Y, Meng Q, Zhan
L, Su W, Liu H, Xu J, Liu Z, et al: Selective inhibition of PTEN
preserves ischaemic post-conditioning cardioprotection in
STZ-induced type 1 diabetic rats: Role of the PI3K/Akt and
JAK2/STAT3 pathways. Clin Sci (Lond). 130:377–392. 2016. View Article : Google Scholar
|
|
33
|
Yu L, Liang H, Dong X, Zhao G, Jin Z, Zhai
M, Yang Y, Chen W, Liu J, Yi W, et al: Reduced silent information
regulator 1 signaling exacerbates myocardial ischemia-reperfusion
injury in type 2 diabetic rats and the protective effect of
melatonin. J Pineal Res. 59:376–390. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu R, Smeele KM, Wyatt E, Ichikawa Y,
Eerbeek O, Sun L, Chawla K, Hollmann MW, et al: Reduction in
hexokinase II levels results in decreased cardiac function and
altered remodeling after ischemia/reperfusion injury. Circ Res.
108:60–69. 2011. View Article : Google Scholar
|
|
35
|
Toldo S, Breckenridge DG, Mezzaroma E, Van
Tassell BW, Shryock J, Kannan H, Phan D, Budas G, Farkas D,
Lesnefsky E, et al: Inhibition of apoptosis signal-regulating
kinase 1 reduces myocardial ischemia-reperfusion injury in the
mouse. J Am Heart Assoc. 1:e0023602012. View Article : Google Scholar
|
|
36
|
Chen WC, Hsieh SR, Chiu CH, Hsu BD and
Liou YM: Molecular identification for
epigallocatechin-3-gallate-mediated antioxidant intervention on the
H2O2-induced oxidative stress in H9c2 rat
cardiomyoblasts. J Biomed Sci. 21:562014. View Article : Google Scholar
|
|
37
|
Li H, Bian Y, Zhang N, Guo J, Wang C, Lau
WB and Xiao C: Intermedin protects against myocardial
ischemia-reperfusion injury in diabetic rats. Cardiovasc Diabetol.
12:912013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang B, Yang Q, Bai WW, Xing YF, Lu XT,
Sun YY and Zhao YX: Tongxinluo protects against pressure
overload-induced heart failure in mice involving VEGF/Akt/eNOS
pathway activation. PLoS One. 9:e980472014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Eguchi M, Kim YH, Kang KW, Shim CY, Jang
Y, Dorval T, Kim KJ and Sweeney G: Ischemia-reperfusion injury
leads to distinct temporal cardiac remodeling in normal versus
diabetic mice. PLoS One. 7:e304502012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu J, Tang Y, Feng Z, Hou C, Wang H, Yan
J, Liu J, Shen W, Zang W, Liu J, et al: Acetylated FoxO1 mediates
high-glucose induced autophagy in H9c2 cardiomyoblasts: Regulation
by a polyphenol -(−)-epigallocatechin-3-gallate. Metabolism.
63:1314–1323. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Alcendor RR, Gao S, Zhai P, Zablocki D,
Holle E, Yu X, Tian B, Wagner T, Vatner SF and Sadoshima J: Sirt1
regulates aging and resistance to oxidative stress in the heart.
Circ Res. 100:1512–1521. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Puthanveetil P, Wan A and Rodrigues B:
FoxO1 is crucial for sustaining cardiomyocyte metabolism and cell
survival. Cardiovasc Res. 97:393–403. 2013. View Article : Google Scholar
|
|
43
|
Salminen A, Kaarniranta K and Kauppinen A:
Crosstalk between oxidative stress and SIRT1: Impact on the aging
process. Int J Mol Sci. 14:3834–3859. 2013. View Article : Google Scholar : PubMed/NCBI
|
